1 / 7Texmaco Rail & Engineering | Kolkata-based engineering and infrastructure company on Tuesday announced the launch of its Qualified Institutional Placement (QIP) to raise ₹750 crore, which includes a green shoe option of ₹200 crore. The indicative price for the QIP is set at ₹129.1, representing a 13.4% discount to the current market price.
2 / 7TCS | India's largest IT services company on Tuesday said the company faced a setback as the United States Supreme Court declined the company's petition to appeal against the US Court of Appeals' decision. The ruling upholds the punitive damages award of $140 million in the EPIC Systems Corporation case, originally passed by the District Court of Wisconsin, TCS said in a regulatory filing.
3 / 7Jio Financial Services | The demerged non-banking financial services unit of Reliance Group on Tuesday said currently it has no plans to raise money by way of bond issuance or otherwise. "We wish to clarify that currently, the company has no plans to raise money by way of bond issuance or otherwise. The news item is speculative," it said in a statement.
4 / 7BPCL | State-owned company on Tuesday said the company is planning to consider a proposal to declare an interim dividend for the financial year 2023-24 on November 29. "It is further notified that the Trading Window in terms of 'The Code for Prevention of Insider Trading in the securities of BPCL' shall remain closed from November 22, 2023,to December 1, 2023," the company added.
5 / 7Wipro | IT major on Tuesday announced a collaboration with NVIDIA to help healthcare companies accelerate the adoption of generative artificial intelligence (AI). Wipro will leverage NVIDIA's AI software for enterprises for the production of AI across its current portfolio of healthcare solutions in the Affordable Care Act (ACA), Medicare, and Medicaid.
6 / 7Lupin | Pharma major on Tuesday announced that it has received tentative approval from the United States Food and Drug Administration for its abbreviated new drug application for Dapagliflozin Tablets. The tablets are used to treat type 2 diabetes. The company said that the product will be manufactured at Lupin's Pithampur facility.
7 / 7SBI | The state lender on Tuesday changed the portfolios of some of its top officials with the appointment of Vinay M Tonse as the fourth managing director of the bank. Tonse will now look after retail banking and operations, SBI said in a regulatory filing. The portfolio was with Alok Kumar Choudhary earlier.
